In vitro growth activity of novel purine- and pyrimidine-based CDK1 and CDK2 inhibitors.

被引：0
|
作者：
Arris, CE
Boyle, FT
Calvert, AH
Curtin, NJ
Dewsbury, PJ
Endicott, JA
Gibson, AE
Golding, BT
Grant, S
Griffin, RJ
Johnson, LN
Noble, MEM
Newell, DR
Sausville, E
Schultz, R
机构：
[1] Univ Newcastle Upon Tyne, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Univ Oxford, Oxford OX1 3QU, England
[3] NCI, DTP, Washington, DC USA
[4] Zeneca Pharmaceut, Macclesfield SK10 4TG, Cheshire, England
来源：
BRITISH JOURNAL OF CANCER | 1999年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
110
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [31] Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK Inhibition
    Wood, Daniel J.
    Korolchuk, Svitlana
    Tatum, Natalie J.
    Wang, Lan-Zhen
    Endicott, Jane A.
    Noble, Martin E. M.
    Martin, Mathew P.
    CELL CHEMICAL BIOLOGY, 2019, 26 (01): : 121 - +
  • [32] Combined depletion of cdk2, cdk1 and cdk9 activities induces apoptosis in cancer cells
    Cai, Dongpo
    Latham, Vaughan M.
    Zhang, Xinxin
    Shapiro, Geoffrey I.
    CANCER RESEARCH, 2006, 66 (08)
  • [33] FOXM1c is activated by cyclin E/Cdk2, cyclin A/Cdk2, and cyclin A/Cdk1, but repressed by GSK-3α
    Wierstra, Inken
    Alves, Juergen
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 348 (01) : 99 - 108
  • [34] Synthesis of 6-(het) ary Xylocydine analogues and evaluating their inhibitory activities of CDK1 and CDK2 in vitro
    Xiao, Chuan
    Sun, Chao
    Han, Weiwei
    Pan, Feng
    Dan, Zhu
    Li, Yu
    Song, Zhi-Guang
    Jin, Ying-Hua
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (23) : 7100 - 7110
  • [35] The Interactions Between Purine-Pyrimidine Derivatives and CDK2 Based on Molecular Dynamic Simulation
    Cao, Xiaoning
    Shi, Rongwei
    Zhu, Xiaolei
    JOURNAL OF COMPUTATIONAL AND THEORETICAL NANOSCIENCE, 2012, 9 (12) : 2181 - 2189
  • [36] Selective chemical inhibition as a tool to study Cdk1 and Cdk2 functions in the cell cycle
    Krasinska, Liliana
    Cot, Emilie
    Fisher, Daniel
    CELL CYCLE, 2008, 7 (12) : 1702 - 1708
  • [37] Exploring the selectivity of a ligand complex with CDK2/CDK1: a molecular dynamics simulation approach
    Tripathi, Sunil Kumar
    Singh, Sanjeev Kumar
    Singh, Poonam
    Chellaperumal, Palanisamy
    Reddy, Karnati Konda
    Selvaraj, Chandrabose
    JOURNAL OF MOLECULAR RECOGNITION, 2012, 25 (10) : 504 - 512
  • [38] 胃癌中CDK1和CDK2的表达及预后意义
    颜伟
    张永红
    何乐亚
    魏欣
    陶德定
    胡俊波
    龚建平
    中国组织化学与细胞化学杂志, 2010, 19 (02) : 165 - 167
  • [39] RINGO/Speedy proteins, a family of non-canonical activators of CDK1 and CDK2
    Gonzalez, Laura
    Nebreda, Angel R.
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2020, 107 : 21 - 27
  • [40] SYNTHESIS OF NOVEL PYRROLOPYRIMIDINE DERIVATIVES AS CDK2 INHIBITORS
    Abd El-Hameed, Rania H.
    Sayed, Amira I.
    PHARMACOPHORE, 2018, 9 (05): : 29 - 49
12345